"In terms of (inspection) activity (in India) we are getting closer to pre-pandemic levels," Sarah McMullen, country director - India at US Food and Drug Administration (USFDA) told ET, at the sidelines of a recent industry event in Mumbai.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/J30EUdw
via IFTTT
0 comments:
Post a Comment